D012595DisordersC17.300.799C17.800.784780.993505Scleroderma, Systemicprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonPathologyWake Forest School of MedicineCarlosFerrarioCarlos M. Ferrario MD36.09032400000000-80.26649100000000132Ferrario, CarlosProfessor EmeritusCarlLangefeldCarl D. Langefeld PhD36.09550200000000-80.24393700000000149Langefeld, CarlProfessorMarkChappellMark C. Chappell PhD36.09032400000000-80.26649100000000616Chappell, MarkProfessorOmarSanguezaOmar P. Sangueza MD36.08959100000000-80.26859900000000736Sangueza, OmarProfessor26715139Bonnecaze AKBMJ case reportsBonnecaze AK. Raynaud's phenomenon in limited cutaneous systemic sclerosis. BMJ Case Rep. 2015 Dec 29; 2015.BMJ Case Rep2015-12-29T00:00:002015Raynaud's phenomenon in limited cutaneous systemic sclerosis.30947741Ramos PS, Zimmerman KD, Haddad S, Langefeld CD, Medsger TA, Feghali-Bostwick CAClinical epigeneticsRamos PS, Zimmerman KD, Haddad S, Langefeld CD, Medsger TA, Feghali-Bostwick CA. Integrative analysis of DNA methylation in discordant twins unveils distinct architectures of systemic sclerosis subsets. Clin Epigenetics. 2019 04 04; 11(1):58.Clin Epigenetics2019-04-04T00:00:002019Integrative analysis of DNA methylation in discordant twins unveils distinct architectures of systemic sclerosis subsets.Internal Medicine, Molecular MedicinePHS-Biostatistics and Data Science (Public Health Sciences)Surgery, GeneralSurgery, HypertensionKipZimmermanKip D. Zimmerman PhD3184Zimmerman, KipAssistant Professor34750102Malaab M, Renaud L, Takamura N, Zimmerman KD, da Silveira WA, Ramos PS, Haddad S, Peters-Golden M, Penke LR, Wolf B, Hardiman G, Langefeld CD, Medsger TA, Feghali-Bostwick CAAnnals of the rheumatic diseasesMalaab M, Renaud L, Takamura N, Zimmerman KD, da Silveira WA, Ramos PS, Haddad S, Peters-Golden M, Penke LR, Wolf B, Hardiman G, Langefeld CD, Medsger TA, Feghali-Bostwick CA. Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis. Ann Rheum Dis. 2022 02; 81(2):268-277.Ann Rheum Dis2021-11-08T00:00:002021Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis.true1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1Professor EmeritusProfessor Emeritustrue1ProfessorProfessor22774391Ilonze OJ, Ritter NJournal of the National Medical AssociationIlonze OJ, Ritter N. The optimal management of patients with systemic scleroderma and coronary artery disease. J Natl Med Assoc. 2012 Mar-Apr; 104(3-4):215-8.J Natl Med Assoc2012-03-01T00:00:002012The optimal management of patients with systemic scleroderma and coronary artery disease.20602809Chappell MCArthritis research & therapyChappell MC. Angiotensin-converting enzyme 2 autoantibodies: further evidence for a role of the renin-angiotensin system in inflammation. Arthritis Res Ther. 2010; 12(3):128.Arthritis Res Ther2010-06-28T00:00:002010Angiotensin-converting enzyme 2 autoantibodies: further evidence for a role of the renin-angiotensin system in inflammation.0.3884310.06356057research area of0.8521620.13476913subject area for